HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients.

Abstract
Over a 15-month period, 75 critically ill patients at risk of acute gastrointestinal bleeding were randomized into two groups: one group (38 patients) received the H2-blocker cimetidine intravenously at an initial dosage of 300 mg every six hours, and the other group (37 patients) received antacid (Mylanta II) through a nasogastric tube at an intial dosage of 30 ml every hour. Gastric pH was measured hourly and titrated above 3.5. Upper-gastrointestinal-tract bleeding occurred in seven of 38 cimetidine-treated patients but in none of 37 antacid-treated patients (P less than 0.01). When antacid titration was added to the cimetidine regimen in four of seven patients with bleeding, all four stopped bleeding. Renal failure, sepsis, peritonitis, hypotension, respiratory failure, jaundice, multiple trauma, and major operative procedures were associated with an increased incidence of bleeding. Cimetidine does not adequately protect seriously ill patients from acute upper-gastrointestinal-tract bleeding. Antacid is better for this purpose.
AuthorsH J Priebe, J J Skillman, L S Bushnell, P C Long, W Silen
JournalThe New England journal of medicine (N Engl J Med) Vol. 302 Issue 8 Pg. 426-30 (Feb 21 1980) ISSN: 0028-4793 [Print] United States
PMID6986027 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antacids
  • Drug Combinations
  • Guanidines
  • aluminum hydroxide, magnesium hydroxide, simethicone drug combination
  • Aluminum Hydroxide
  • Cimetidine
  • Simethicone
  • Magnesium Hydroxide
Topics
  • Acute Disease
  • Aluminum Hydroxide (therapeutic use)
  • Antacids (administration & dosage, therapeutic use)
  • Cimetidine (administration & dosage, therapeutic use)
  • Clinical Trials as Topic
  • Critical Care
  • Drug Combinations
  • Female
  • Gastrointestinal Hemorrhage (prevention & control)
  • Guanidines (therapeutic use)
  • Humans
  • Intubation, Gastrointestinal
  • Magnesium Hydroxide (therapeutic use)
  • Male
  • Middle Aged
  • Postoperative Care
  • Postoperative Complications (prevention & control)
  • Random Allocation
  • Risk
  • Simethicone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: